#72 Notable Clinical Interest
Emerging findings or policy developments worth monitoring closely.
If you are a parent or caregiver of a teenager, this research underscores why adolescent cannabis use should only occur under direct medical supervision with careful psychiatric screening, and why recreational or unsupervised use during brain development carries meaningful risk.
Research continues to explore the association between adolescent cannabis use and the development of psychiatric disorders, including psychosis, depression, and bipolar spectrum conditions. While these correlational findings are important to acknowledge, clinicians must also consider confounding variables such as pre-existing mental health conditions, adverse childhood experiences, genetic predisposition, and the role of self-medication that may drive early cannabis use in vulnerable youth. From a clinical standpoint, the developing adolescent brain warrants a distinctly cautious approach to cannabinoid exposure, and these findings reinforce the importance of age-appropriate screening and guided medical oversight rather than unmonitored recreational access.
“Correlation is not causation, but the adolescent brain is not the place to test that distinction, and every one of these studies reminds us that cannabis medicine for young people demands rigorous medical oversight, not a hands off approach.”
? Another study draws attention to the link between adolescent cannabis use and psychiatric outcomes, a topic that demands nuance rather than headlines. The developing brain operates under different rules than the adult brain, and THC exposure during critical windows of neurodevelopment may carry disproportionate risk for mood disorders, psychotic spectrum conditions, and cognitive changes. ️ However, we must be careful not to confuse association with causation — many adolescents who turn to cannabis are already struggling with untreated anxiety, trauma, or emerging psychiatric illness. ️ In my clinic, when we encounter adolescent patients, the standard is thorough psychiatric evaluation, conservative dosing, parental involvement, and ongoing monitoring — the opposite of what recreational access provides. The takeaway is not that cannabis is inherently dangerous for all young people, but that unsupervised adolescent use without medical guidance is a gamble no developing brain should take.
Dr Caplan’s review of the JAMA Health Forum paper, including what the methods do and do not allow us to conclude: Adolescent Cannabis Use and Psychosis Risk – Study Review
? Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
